FRβ is a protein universally expressed on M2 TAMs and studies demonstrated solid tumors pretreated with CAR T-cells targeting FRβ improves pro-inflammatory monocytes enrichment and tumor-specific CAR T-cells efficacy (107). This evidence concerns the gene FOLR2 and neoplasm.